Curtailing pollution must to reduce superbugs: UN report, Health News, ET HealthWorld

New Delhi: Curtailing pollution created by pharmaceuticals, agricultural and healthcare sectors is essential to reduce the emergence, transmission, and spread of superbugs – strains of bacteria that have become resistant to every known antibiotic – and other instances of antimicrobial resistance, known as AMR. This is the key message of a report released on Tuesday by the UN Environment Programme (UNEP) on the environmental dimensions of AMR, which already is taking a serious toll on the health of humans, animals, and plants, as well as the economy. The report, ‘Bracing…

Read More

Centre “forcefully” stopped Pfizer’s COVID vaccine: KCR hits out at Modi-government, Health News, ET HealthWorld

Nanded: Telangana Chief Minister K Chandrashekar Rao has alleged that the Central government did everything possible to “forcefully” prevent import of COVID-19 vaccines from Pfizer, especially when people were ready to get the best vaccine. Rao claimed that he and several other Chief Ministers had lobbied for Pfizer in India, but the PM Modi Government stalled the entry of the US pharmaceutical giant into India The Chief Minister’s remark at his recent rally in Maharashtra’s Nanded came days after Union Minister of State for Electronics and Technology Rajeev Chandrasekhar claimed…

Read More

Integrative Medicine Centres will start at govt medical sites: Mansukh Mandaviya, Health News, ET HealthWorld

New Delhi: The Centre has decided to open Integrative Medicine Centres at all government medical establishments in the country especially at AIIMS, Union Health Minister Mansukh Mandaviya said on Tuesday. He emphasized that the Government has decided to open such Integrative Medicine Centres at all government medical establishments, especially all AIIMS in the country. “Opening such Centres will help in initiating co-location of practitioners of the Indian system and modern medicine, thus harmonizing both medical systems and providing joint multidisciplinary care to the patients,” he said. Emphasizing the significance of…

Read More

DGGI, NFSU sign MoU for setting up digital forensic laboratories, Health News, ET HealthWorld

New Delhi: The Directorate General of GST Intelligence (DGGI) and the National Forensic Sciences University (NFSU) on Tuesday signed a Memorandum of Understanding (MoU) for setting up digital forensic laboratories, along with the exchange of information and knowledge, technological advancement and skill development in the field of digital forensics. The MoU was signed by Pr Director General DGGI Surjit Bhujabal and JM Vyas, Vice Chancellor, NFSU, Gandhinagar. DGGI is the apex intelligence organisation under the Central Board of Indirect Taxes and Customs (CBIC) for the collection and dissemination of information…

Read More

Turkey, Syria quake could affect up to 23 mn: WHO, Health News, ET HealthWorld

Geneva: Up to 23 million people could be affected by the massive earthquake that has killed thousands in Turkey and Syria, the WHO warned on Tuesday, promising long-term assistance. “Event overview maps show that potentially 23 million people are exposed, including around five million vulnerable populations,” the World Health Organization’s senior emergencies officer Adelheid Marschang said. “Civilian infrastructure and potentially health infrastructure have been damaged across the affected region, mainly in Turkey and northwest Syria,” she said. The WHO “considers that the main unmet needs may be in Syria in…

Read More

Bharat Biotech dispatches first shipments of iNCOVACC across India, Health News, ET HealthWorld

New Delhi: The Bharat Biotech on Monday dispatched the first shipments of the World‘s first intranasal Covid19 vaccine iNCOVACC to various locations across India. “The first shipments of #iNCOVACC are being dispatched to various locations across #India. A moment of pride and accomplishment for team @BharatBiotech,” Bharat Biotech said in a tweet. On Sunday Dr Krishna Ella, Executive Chairman, Bharat Biotech said that Bharat Biotech Pvt Ltd has started dispatching World’s first Intranasal heterologous booster dose to hospitals. “We have just dispatched nasal vaccines two days ago to the hospitals,”…

Read More

PLI scheme attracted Rs 45,000 cr investment, created 3 lakh jobs: NITI Aayog CEO, Health News, ET HealthWorld

New Delhi: India’s production-linked incentive (PLI) scheme has attracted investment worth over Rs 45,000 crore and has also created three lakh jobs, according to NITI Aayog CEO Parameswaran Iyer. “The PLI programme has already started showing results. About Rs 800 core have already been paid by way of incentives. We are expecting (incentives) to go close to Rs 3,000 crore to Rs 4,000 core before March,” Iyer told PTI. “The scheme is working. Already about Rs 45,000 crore-plus investment has come in, three lakh jobs have been created and production…

Read More

India registers 89 new COVID-19 cases, active cases stand at 1,771, Health News, ET HealthWorld

New Delhi: With the COVID-19 pandemic slowly fading out, India’s daily COVID-19 cases stand at 89 in the last 24 hours. While the active cases in the country stand at 1,771, which is 0.01 per cent, a health bulletin from the Union Health Ministry stated. A total of 91.33 crore COVID-19 tests have been conducted so far; 74,320 tests conducted in last 24 hours. The daily positivity rate is 0.07 per cent and the weekly positivity rate is 0.08 per cent. “India has administered 220.59 crore total vaccine doses (95.19…

Read More

Study reveals antibody therapy for treating liver disease, Health News, ET HealthWorld

Solna: There is presently no medication available to treat non-alcoholic fatty liver disease, which affects many patients with type 2 diabetes and can lead to other serious liver illnesses. A therapeutic candidate for the treatment of fatty liver has been identified in a study headed by Karolinska Institutet researchers. The study published in the Journal of Hepatology, indicates that an antibody that blocks the protein VEGF-B presents a possible therapeutic option for fatty liver disease. “Fatty liver is associated with several serious and sometimes fatal diseases,” said the study’s first…

Read More

Pfizer: Drug companies face COVID cliff in 2023 as sales set to plummet, Health News, ET HealthWorld

New York: Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up against a steep COVID cliff and investor pressure to spend their windfalls wisely. Western drugmakers including Pfizer Inc, BioNTech SE, Moderna Inc, Gilead Sciences Inc, AstraZeneca Plc, and Merck & Co are estimated to have brought in about $100 billion in revenue from COVID vaccines and treatments in 2022. Company and analyst estimates suggest those sales could fall by nearly two-thirds this year due to built up product…

Read More